TXG - 10x Genomics, Inc. -  [ ]

Ticker Details
10x Genomics, Inc.
IPO Date: September 12, 2019
Sector: Healthcare
Industry: Health Information Services
Market Cap: $5.47B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.82 | 3.07%
Avg Daily Range (30 D): $1.44 | 4.42%
Avg Daily Range (90 D): $1.01 | 3.96%
Institutional Daily Volume
Avg Daily Volume: 1.29M
Avg Daily Volume (30 D): 2.7M
Avg Daily Volume (90 D): 2.29M
Trade Size
Avg Trade Size (Sh.): 65
Avg Trade Size (Sh.) (30 D): 61
Avg Trade Size (Sh.) (90 D): 59
Institutional Trades
Total Institutional Trades: 5,119
Avg Institutional Trade: $3.84M
Avg Institutional Trade (30 D): $5.01M
Avg Institutional Trade (90 D): $4.44M
Avg Institutional Trade Volume: .09M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $7.15M
Avg Closing Trade (30 D): $18.94M
Avg Closing Trade (90 D): $11.82M
Avg Closing Volume: 178.19K
 
News
Jun 30, 2026 @ 11:58 AM
Spatial Genomics and Transcriptomics Market Size t...
Source: Sns Insider
May 12, 2026 @ 4:39 PM
This $4 Million Bet Shows Growing Confidence in 10...
Source: Jonathan Ponciano
Apr 10, 2026 @ 9:45 AM
Global Next-Generation Sequencing (NGS) Market to ...
Source: Researchandmarkets.Com
Mar 23, 2026 @ 11:07 AM
These Are the Only 3 Stocks That Cathie Wood Bough...
Source: Rick Munarriz
Jan 20, 2026 @ 5:05 AM
Cathie Wood's Ark Unleashes Cryptic ARKmoji Teaser...
Source: Vishaal Sanjay
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-.17 $-.1 $-.13
Diluted EPS $-.17 $-.1 $-.13
Revenue $638.78M $150.84M $166.03M
Gross Profit $444.61M $106.18M $113.05M
Net Income / Loss $-22.66M $-13.47M $-16.25M
Operating Income / Loss $-38.7M $-17.05M $-19.54M
Cost of Revenue $194.17M $44.67M $52.99M
Net Cash Flow $113.22M $16.32M $41.26M
PE Ratio